Design, synthesis and biological evaluation of pyrazolyl-thiazolinone derivatives as potential EGFR and HER-2 kinase inhibitors
- 15 March 2012
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry
- Vol. 20 (6), 2010-2018
- https://doi.org/10.1016/j.bmc.2012.01.051
Abstract
No abstract availableKeywords
Funding Information
- The National Natural Science Foundation of China (NSFC J1103512)
This publication has 21 references indexed in Scilit:
- Design, synthesis and biological evaluation of thiazolidinone derivatives as potential EGFR and HER-2 kinase inhibitorsBioorganic & Medicinal Chemistry, 2010
- An Allosteric Mechanism for Activation of the Kinase Domain of Epidermal Growth Factor ReceptorCell, 2006
- Identification of antitumor activity of pyrazole oxime ethersBioorganic & Medicinal Chemistry Letters, 2005
- Design, synthesis and anti-microbial activity of 1H-pyrazole carboxylatesBioorganic & Medicinal Chemistry Letters, 2004
- Synthesis and antiproliferative activity of 2-aryl-4-oxo-thiazolidin-3-yl-amides for prostate cancerBioorganic & Medicinal Chemistry Letters, 2004
- Synthesis and Antibacterial Activity of a Novel Series of Potent DNA Gyrase Inhibitors. Pyrazole DerivativesJournal of Medicinal Chemistry, 2004
- The Role of the Epidermal Growth Factor Receptor Family in Mammary Tumorigenesis and MetastasisExperimental Cell Research, 1999
- Small molecule inhibitors of receptor tyrosine kinasesDrugs of the Future, 1999
- ω‐Dialkylaminoalkyl ethers of phenyl‐(5‐substituted 1‐phenyl‐1H‐pyrazol‐4‐yl)methanols with analgesic and anti‐inflammatory activityJournal of Heterocyclic Chemistry, 1997
- Pyrazole-related nucleosides. Synthesis and antiviral/antitumor activity of some substituted pyrazole and pyrazolo[4,3-d]-1,2,3-triazin-4-one nucleosidesJournal of Medicinal Chemistry, 1992